Technology
INTELLECTUAL PROPERTY
Expert Witness Testimony
Bryan is a tested expert witness in intellectual property and patent cases representing companies that develop and market medical devices, medical software and hospital information systems. Serving top law firms and Fortune 500 companies, he is also a valued consultant in the preparation of cases. An established expert in technology and medical informatics, he provides credible testimony based on numerous published works—peer-reviewed research, chapters in texts and books he has authored and co-authored.
His experience with his own inventions and developing intellectual property for clients enables Bryan to understand the complexities of medical technology and explain them with authority. He offers clear, convincing and substantiated testimony after meticulous review of the material related to the case and documentation about prior art and other elements of related intellectual property.
Patent Portfolio Analysis
A company’s patent portfolio is a potential source of revenue from both product development and patent sales and/or licensing. Strategic alliance opportunities and pursuit of patent infringements offer additional opportunities. Surprisingly, many major companies don’t know the value of their patents or understand the interrelationships between their intellectual property and product marketability. An in-depth patent analysis can offer significant benefits both by developing opportunities and by protecting intellectual property.
The expertise required for IP portfolio analysis is comprehensive including scientific knowledge, computer skills, business and marketing savvy and experience with product development and IP litigation. Bryan Bergeron’s diverse talents uniquely qualify him to undertake these complex endeavors because he sees connections and opportunities others might miss. His hands-on skills enable him to undertake reverse-engineering tasks when required.
Due Diligence
Technology-dependent deals—mergers, acquisitions or start-ups—require expert review of intangible assets to guard against unexpected liabilities and to assure anticipated benefits. Buying, selling and/or licensing intellectual property is a complex process that requires a highly skilled and experienced team. For venture capital firms and business executives alike, a successful venture depends on getting not only accurate business advice, but also cogent and comprehensive technical and scientific input.
Bryan Bergeron’s exceptional background qualifies him to wear more than one hat on the team. As a physician skilled in technology, he combines the perspective of the medical community with the knowledge of a researcher. Because of his extensive business experience, he adds a practical point of view sometimes lacking in technologists and healthcare professionals. Perhaps most important of all, he is an asset to any team, deeply sensitive to timelines and priorities as well as to the need for penetrating analysis.
PROJECT ARCHITECTURE
Innovative technology projects meet their objectives when new and existing technologies are effectively combined to produce a practical result that can be translated into cost-effective implementation. Successfully doing things for the first time requires a wide knowledge of technology and a keen sense of the possible. Bryan Bergeron excels at this process. In collaboration with client teams, he develops a vision of the desired outcome and assembles the specs to build the product.
He has worked on numerous projects for the US military as well as industry—frequently under the aegis of TATRC (Telemedicine and Advanced Technology Research Center), DOD (Department of Defense) and SBIR (Small Business Innovation Research).
CHIEF SCIENTIST CONSULTING
New product development in the medical industry requires a blend of scientific expertise, business knowledge and familiarity with medical practice. Engineering skill and intellectual property experience are helpful as well. When a full-time chief scientist position is not appropriate, companies often consider a consulting chief scientist.
In this capacity, Bryan Bergeron serves as a resource and mentor to the development team as well as being an advisor to management. He is a conduit to academia. And he provides a sounding board for research projects, original ideas and innovative approaches. He helps the team set priorities, apply new science and technology and predict future trends.